News Pfizer and Catalia's robot wellness coach aims to help patie... Pfizer and Catalia Health have launched a year-long pilot scheme exploring how patients engage with cute robot companions that use artificial intelligence (AI) to check on symptom managemen
News GSK suffers a setback with its TIM-3 programme GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor TIM-3.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
